Patent details
EP1309557
Title:
AMLODIPINE HEMIMALEATE
Basic Information
- Publication number:
- EP1309557
- PCT Application Number:
- PCT/NL/2001/000602
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP019749845
- PCT Publication Number:
- WO/2002/053539
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- AMLODIPINE HEMIMALEATE
- French Title of Invention:
- AMLODIPINE HEMIMALEATE
- German Title of Invention:
- AMLODIPIN-HEMIMALEAT
- SPC Number:
-
Dates
- Filing date:
- 15/08/2001
- Grant date:
- 04/01/2006
- EP Publication Date:
- 04/01/2006
- PCT Publication Date:
- 11/07/2002
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 14/05/2003
- EP B1 Publication Date:
- 04/01/2006
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 15/08/2006
- Expiration date:
- 15/08/2021
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 15/08/2001
-
-
- Name:
- Pfizer Limited
- Address:
- 261 Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom (GB)
Inventor
- Name:
- ETTEMA Gerrit, Jan, Bouke
- Address:
- Netherlands (NL)
Priority
1
- Priority Number:
- 258603 P
- Priority Date:
- 29/12/2000
- Priority Country:
- United States (US)
2
- Priority Number:
- 809356
- Priority Date:
- 16/03/2001
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
C07D 211/90;
Filing date |
Document type |
Number of pages |